faculty of medicine, Cairo university
Cairo, Egypt
NCT Number: NCT05018364
This study is to evaluate brain and kidney injuries in full-term neonates with perinatal asphyxia by detecting specific biomarker in blood (Erythropoietin).
Looking for future studies?
Notify Me1 day–4 day
All sexes
Observational
Cairo, Egypt
Perinatal hypoxic-ischemic encephalopathy (HIE) is an important cause of brain injury in the newborn and can result in long-term devastating consequences. Acute kidney injury (AKI) occurs in (50 - 72%) among asphyxiated term infants. The kidney cells that make erythropoietin are sensitive to low oxygen levels in the blood that travels through the kidney. These cells make and release erythropoietin when the oxygen level is too low.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Cases group:
Control group:
Newborns who were delivered normally after uncomplicated pregnancy. None of them have clinical nor biochemical signs of asphyxia.
Exclusion criteria
Evaluate serum erythropoietin level in neonates exposed to hypoxia compared to control group
Time frame: first 4 days of life
measure level of serum erythropoietin by ELISA technique and test if can differentiate degree of brain hypoxia
Cairo University
Other
Serum Erythropoietin Level for Detection of Kidney and Brain Injuries in Asphyxiated Neonates in Neonatal Intensive Care Unit.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03407729
Brain Diseases, Central Nervous System Diseases
Cleveland, Ohio, United States
View Trial DetailsNCT06930274
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Death
Vancouver, British Columbia, Canada
View Trial DetailsNCT04913324
Brain Damage, Chronic, Brain Diseases
Toronto, Ontario, Canada
View Trial Details